Integrated Filing — IndAS



General information about company

Scrip Code 000000
NSE Symbol OSWALSEEDS
MSEI Symbol NOTLISTED
ISIN INE00IK01029
Name of company SHREEOSWAL SEEDS AND CHEMICALS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 14-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 03-11-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Agro Seed Processing
Start date and time of board meeting 14-11-2026   17:30:00
End date and time of board meeting 14-11-2026   18:50:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public No
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. No
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 14-02-2025
Indicate Company website link for updated RPT policy of the Company https://www.oswalseeds.com/files/Policy/related%20party%20policy_Oswal_14.02.2025.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There is no default on loan and debt securities hence disclosure is not applicable on the Company.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 1,115.52 8,719.69
Other income 30.74 50.25
Total income 1,146.26 8,769.94
2 Expenses
(a) Cost of materials consumed 349.02 3,206.04
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 785.37 3,856.35
(d) Employee benefit expense 80.58 166.75
(e) Finance costs 55.95 96.27
(f) Depreciation, depletion and amortisation expense 12.97 26.25
(f) Other Expenses
1 Selling & distribution Scheme 12.84 13.27
2 Travelling Expenses 18.06 30.49
3 Advertisment 55.21 55.71
4 Freight Expenses (outward) 0.00 120.64
5 Other Expenses 21.56 37.72
Total other expenses 107.67 257.83
Total expenses 1,391.56 7,609.49
3 Total profit before exceptional items and tax (245.30) 1,160.45
4 Exceptional items 0.00 0.00
5 Total profit before tax (245.30) 1,160.45
6 Tax expense
7 Current tax (68.77) 322.15
8 Deferred tax 0.57 0.55
9 Total tax expenses (68.20) 322.70
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations (177.10) 837.75
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period (177.10) 837.75
17 Other comprehensive income net of taxes 0.00 0.00
18 Total Comprehensive Income for the period (177.10) 837.75
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,829.40 1,829.40
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -0.19 0.92
Diluted earnings (loss) per share from continuing operations -0.19 0.92
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -0.19 0.92
Diluted earnings (loss) per share from continuing and discontinued operations -0.19 0.92
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The above Un-audited standalone and consolidated financial results for the quarter as well as six month ended September 30, 2026 were reviewed and recommended by the Audit Committee and approved by the Board of Directors in its meeting held on 14th November, 2026. The above Un-audited standalone and consolidated results have been reviewed by Statutory Auditors of the Company in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, who have expressed an unmodified opinion. 2. The above statement have been prepared in accordance with the guidelines issued by the Securities and Exchange Board of India (SEBI) and the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) prescribed under Section 133 of the Companies Act and other recognized accounting practices and policies to the extent applicable. 3. The above consolidated financial results include the result of Wholly Owned Subsidiary Company i.e. Shreeoswal Psyllium Exports India Limited. 4. The Company has no reportable segment on standalone basis and on consolidated basis the Company has two reportable segments which consist of Seed and Psyllium in accordance with Ind AS-108 Operating Segment. 5. The aforesaid Un-audited standalone and consolidated Financial Results will be uploaded on the Company's website http://www.oswalseeds.com and will also be available on the website of the NSE www.nseindia.com for the benefit of shareholders and investors. Further, publication containing a Quick Response code and the details of the webpage where complete financial results of the Company are available, will be published in English and Hindi Newspapers with in prescribed time limit. 6. The Un-audited standalone and consolidated Statement of Assets & Liabilities as at September 30, 2026 is annexed with the financial results along with the Cash Flow Statements. 7. Figures for the previous / year have been rearranged/regrouped, restated, reclassified and/or recasted wherever considered necessary to correspond with the figures of the Current period / Year. All figures of financials have been rounded off to nearest Lakhs Rupees.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 537.50
Capital work-in-progress
Investment property
Goodwill 0.00
Other intangible assets 0.00
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 2,001.40
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets
1 Corporate Guarantee Receivables 46.60
2 Capital Advance 4.01
Total of other non-current financial assets 50.61
Total non-current financial assets 2,052.01
Deferred tax assets (net) 19.37
Other non-current assets
Total of other non-current assets
Total non-current assets 2,608.88
2 Current assets
Inventories 5,548.41
Current financial asset
Current investments 0.00
Trade receivables, current 958.13
Cash and cash equivalents 15.89
Bank balance other than cash and cash equivalents 0.00
Loans, current 0.00
Other current financial assets
Total of other current financial assets 12.76
Total current financial assets 986.78
Current tax assets (net) 0.00
Other current assets
1 Advance to Supplier 1,039.79
2 Other current assets 123.39
Total of other current assets 1,163.18
Total current assets 7,698.37
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 10,307.25
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,829.40
Other equity 3,742.24
Total equity attributable to owners of parent 5,571.64
Non controlling interest
Total equity 5,571.64
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 367.83
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Corporate Guarantee Liability 55.36
Total of other non-current financial liabilities 55.36
Total non-current financial liabilities 423.19
Provisions, non-current 49.19
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
1 Security Deposits 6.75
Total of other non-current liabilities 6.75
Total non-current liabilities 479.13
Current liabilities
Current financial liabilities
Borrowings, current 2,441.65
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 159.66
Total Trade payable 159.66
Other current financial liabilities
Total of other current financial liabilities
Total current financial liabilities 2,601.31
Other current liabilities 1,393.35
1 Advance received from Customer 1,368.96
2 Other current liabilities 24.39
Total of other current liabilities 1,393.35
Provisions, current 6.46
Current tax liabilities (Net) 255.36
Deferred government grants, Current
Total current liabilities 4,256.48
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 4,735.61
Total equity and liabilites 10,307.25
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 0.00 0.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 1,160.45
Adjustments for reconcile profit (loss)
Adjustments for finance costs 96.27
Adjustments for decrease (increase) in inventories (1,265.00)
Adjustments for decrease (increase) in trade receivables, current (156.55)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (403.51)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 122.05
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (601.91)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 26.25
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for interest income 46.10
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) (0.48)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (2,228.98)
Net cash flows from (used in) operations (1,068.53)
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 62.92
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (1,131.45)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 22.69
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 46.10
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) investing activities 23.41
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 1,208.42
Repayments of borrowings 0.00
Payments of lease liabilities 0.00
Dividends paid 0.00
Interest paid 96.27
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.50
Net cash flows from (used in) financing activities 1,112.65
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 4.61
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 4.61
Cash and cash equivalents cash flow statement at beginning of period 11.28
Cash and cash equivalents cash flow statement at end of period 15.89





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 SHREEOSWAL SEEDS & CHEMICALS LTD. SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. Wholly Owned Subsidiary Company Loan 0.00 Not Applicable in case of transaction between Holding Company and its wholly owned subsidiary company 3,068.02 0.00 0.00 Loan 9.00 NA Unsecured Business Operation Textual Information(1)
2 SHREEOSWAL SEEDS & CHEMICALS LTD. SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. Wholly Owned Subsidiary Company Interest received 0.00 Not Applicable in case of transaction between Holding Company and its wholly owned subsidiary company 46.10 0.00 0.00
3 SHREEOSWAL SEEDS & CHEMICALS LTD. SANJAY KUMAR BEGANI CHAIRMAN & MANAGING DIRECTOR Remuneration 90.00 As Approved by Audit Committee and members of the company 45.00 0.00 0.00
4 SHREEOSWAL SEEDS & CHEMICALS LTD. ANIL KUMAR NAHTA WHOLETIME DIRECTOR & CEO Remuneration 90.00 As Approved by Audit Committee and members of the company 45.00 0.00 0.00
5 SHREEOSWAL SEEDS & CHEMICALS LTD. DILIP PATIDAR Company Secretary Cum Comliance Officer of Holding Company and its Wholly Owned Subsidiary Company Remuneration 5.00 As Approved by Audit Committee 1.80 0.00 0.00
6 SHREEOSWAL SEEDS & CHEMICALS LTD. ASHOK DHAKAR CFO of Holding Company (Resigned w.e.f. 13.08.2026) Remuneration 5.00 As Approved by Audit Committee 2.40 0.00 0.40
7 SHREEOSWAL SEEDS & CHEMICALS LTD. SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. Wholly Owned Subsidiary Company Any other transaction RENT PAID 3.60 As Approved by Audit Committee 1.80 0.00 0.00
8 SHREEOSWAL SEEDS & CHEMICALS LTD. GOPAL AGARWAL FORMER INDEPENDENT DIRECTOR Any other transaction Outstanding Sitting Fees (Independent Director Resigned w.e.f. 02.04.2025) 0.00 NA 0.00 0.45 0.45
9 SHREEOSWAL SEEDS & CHEMICALS LTD. SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. Wholly Owned Subsidiary Company Investment 0.00 NA 0.00 2,000.00 2,000.00
10 SHREEOSWAL SEEDS & CHEMICALS LTD. OSWAL ETHANOL FEED & INDUSTRY PVT. LTD. COMMON DIRECTOR OF THE COMPANY Any other transaction Corporate Gurantee Income 12.98 As Approved by Audit Committee 0.00 12.76 12.76
11 SHREEOSWAL SEEDS & CHEMICALS LTD. OSWAL ETHANOL FEED & INDUSTRY PVT. LTD. COMMON DIRECTOR OF THE COMPANY Any other transaction Corporate Gurantee 11,000.00 As Approved by Audit Committee and members of the company 0.00 11,000.00 11,000.00
12 SHREEOSWAL SEEDS & CHEMICALS LTD. KRISHAN BAGRI CFO of Holding Company (Appointed w.e.f. 14.08.2026) Remuneration 3.72 As Approved by Audit Committee 1.89 0.00 0.00
13 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. KIRAN DEVI BEGANI WHOLE TIME DIRECTOR Remuneration 24.00 As Approved by Audit Committee 9.00 0.00 0.00
14 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. PADMA NAHTA WHOLE TIME DIRECTOR Remuneration 24.00 As Approved by Audit Committee 9.00 0.00 0.00
15 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. SANJAY KUMAR BEGANI NON- EXECUTIVE DIRECTOR Loan 1,000.00 As Approved by Audit Committee 211.00 0.00 0.00 Textual Information(2)
16 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. SHREEOSWAL SEEDS & CHEMICALS LTD. HOLDING COMPANY Any other transaction Repayment of Loan taken 0.00 Not Applicable in case of transaction between Holding Company and its wholly owned subsidiary company 3,068.02 0.00 0.00
17 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. ANIL KUMAR NAHTA NON- EXECUTIVE DIRECTOR Loan 1,000.00 As Approved by Audit Committee 151.00 0.00 0.00 Textual Information(3)
18 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. SHREEOSWAL SEEDS & CHEMICALS LTD. HOLDING COMPANY Any other transaction RENT PAID 7.20 Not Applicable in case of transaction between Holding Company and its wholly owned subsidiary company 3.60 0.00 0.00
19 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. OSWAL ETHANOL FEED & INDUSTRY PVT. LTD. COMMON DIRECTOR OF THE COMPANY Any other transaction Corporate Gurantee Income 12.98 As Approved by Audit Committee 0.00 12.76 12.76
20 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. OSWAL ETHANOL FEED & INDUSTRY PVT. LTD. COMMON DIRECTOR OF THE COMPANY Any other transaction Corporate Gurantee 11,000.00 As Approved by Audit Committee and members of the company 0.00 11,000.00 11,000.00
21 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. DILIP PATIDAR Company Secretary Cum Comliance Officer of Wholly Owned Subsidiary Company Remuneration 2.00 As Approved by Audit Committee 0.90 0.00 0.00
22 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. ACHARYA KUMAR JAIN CFO of Wholly Owned Subsidiary Company Remuneration 4.00 As Approved by Audit Committee 1.02 0.00 0.00
23 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. SHREEOSWAL SEEDS & CHEMICALS LTD. HOLDING COMPANY Interest paid 0.00 Not Applicable in case of transaction between Holding Company and its wholly owned subsidiary company 46.10 0.00 0.00
24 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. SANJAY KUMAR BEGANI NON- EXECUTIVE DIRECTOR Any other transaction Repayment of Loan taken 1,000.00 As Approved by Audit Committee 211.00 0.00 0.00
25 SHREEOSWAL PSYLLIUM EXPORTS INDIA LTD. ANIL KUMAR NAHTA NON- EXECUTIVE DIRECTOR Any other transaction Repayment of Loan taken 1,000.00 As Approved by Audit Committee 151.00 0.00 0.00
Total value of transaction during the reporting period 7,073.65



Text Block

Textual Information(1) Loan given to Wholly owned Material Subsidiary Company
Textual Information(2) Loan Taken
Textual Information(3) Loan Taken